Orasure Technologies Inc

  • Earnings Score
  • Moat Score
  • Market Cap $290.63M
  • PE 26
  • Debt $NaN
  • Cash $278.57M
  • EV $NaN
  • FCF $64.01M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings$11.37M
EBIT$4.89M
ROE3%
ROA1%
FCF$64.01M
Equity$425.57M
Growth Stability-312%
PE25.57
PEG2.47
PB0.68
P/FCF4.54
P/S1.3
Price/Cash0.96
Net Margins-6%
Gross Margins45%
Op. Margins2%
Earnings CAGR2%
Sales Growth YoY-55%
Sales Growth QoQ-27%
Sales CAGR14%
FCF CAGR5%
Equity CAGR12%
Earnings Stability0.04
Earnings Growth YoY-140%
Earnings Growth QoQ633%
Earnings CAGR 5Y10%
Sales CAGR 5Y22%
FCF CAGR 5Y60%
Equity CAGR 5Y5%
Earnings CAGR 3Y4%
Sales CAGR 3Y4%
FCF CAGR 3Y99%
Equity CAGR 3Y8%
Market Cap$290.63M
Revenue$224.26M
Assets$464.09M
Cash$278.57M
Shares Outstanding74.33M
Earnings Score6%
Moat Score18%
Working Capital322.37M
Current Ratio12.6
Gross Profit$100.95M
Shares Growth 3y1%
Equity Growth QoQ-0%
Equity Growth YoY5%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

SEC Filings

Direct access to Orasure Technologies Inc (OSUR) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Orasure Technologies Inc compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Orasure Technologies Inc compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 2%
Stability 4%
loading chart...

Orasure Technologies Inc Discounted Cash Flow

Fully customizable DCF calculator online for Orasure Technologies Inc.

= $920M
012345678910TV
fcf$64M$67M$71M$75M$79M$83M$87M$92M$97M$102M$107M$1.1B
DCF$61M$59M$56M$54M$51M$49M$47M$45M$43M$41M$413M
Value$920M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Net Margins-4%7%15%19%11%11%-9%-10%-5%13%-6%
ROA-5%10%14%10%6%-1%-2%-4%12%1%
ROE-5%11%12%7%5%-4%-6%-5%12%3%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023TTM
Debt over FCF-----------
Debt over Equity-----------
Growth Stability---100%100%70%-66%-312%---312%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201412/201512/201612/201712/201812/201912/202012/202112/202212/2023CAGR 5Y
Revenue YoY growth-12%7%30%9%-15%11%36%66%5%22%
Earnings YoY growth--277%141%57%-34%-18%-190%54%-22%-399%10%
Equity YoY growth-0%17%39%10%8%30%-5%-4%18%5%
FCF YoY growth-166%68%18%37%-99%-4K%245%-25%-352%60%